1. Home
  2. GNPX vs GWAV Comparison

GNPX vs GWAV Comparison

Compare GNPX & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$1.35

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo Greenwave Technology Solutions Inc.

GWAV

Greenwave Technology Solutions Inc.

HOLD

Current Price

$3.64

Market Cap

3.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
GWAV
Founded
2009
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.6M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
GNPX
GWAV
Price
$1.35
$3.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
272.2K
6.4K
Earning Date
05-11-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,098,036.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
116184.26
52 Week Low
$0.14
$0.07
52 Week High
$12.97
$24.00

Technical Indicators

Market Signals
Indicator
GNPX
GWAV
Relative Strength Index (RSI) 25.92 46.76
Support Level $0.18 $3.56
Resistance Level $2.12 $4.09
Average True Range (ATR) 0.12 0.23
MACD -0.05 0.01
Stochastic Oscillator 6.57 52.05

Price Performance

Historical Comparison
GNPX
GWAV

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

Share on Social Networks: